Drugs that contain Ferric Carboxymaltose

1. List of Injectafer drug patents

INJECTAFER's oppositions filed in EPO
INJECTAFER Litigations
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US11291645 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(4 months from now)

US11590097 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(4 months from now)

US11123321 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(4 months from now)

US9376505 AM REGENT Aqueous iron carbohydrate complexes, their production and medicaments containing them
Oct, 2023

(4 months from now)

US7612109 AM REGENT Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
Feb, 2024

(8 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11433091 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US8895612 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US11478502 AM REGENT Methods and compositions for administration of iron
Jan, 2027

(3 years from now)

US7754702 AM REGENT Methods and compositions for administration of iron
Feb, 2028

(4 years from now)

Do you want to check out INJECTAFER patents from before 2022?
Exclusivity Exclusivity Expiration
New Strength (NS) Apr 28, 2024
New Patient Population (NPP) Nov 19, 2024

Market Authorisation Date: 25 July, 2013

Treatment: Method of treating ida in adult patients with non-dialysis dependent chronic kidney disease & weighing at least 46.7 kg by intravenously administering ferric carboxymaltose to provide at least 0.7 g o...

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of INJECTAFER before it's patent expiration?
More Information on Dosage

INJECTAFER family patents

24

United States

6

European Union

5

Korea, Republic of

3

Spain

3

Hong Kong

3

Denmark

3

Canada

3

Cyprus

3

Portugal

2

Germany

2

China

2

Brazil

2

Norway

2

Japan

2

Jordan

2

Australia

2

Slovenia

1

Uruguay

1

Austria

1

Malaysia

1

Poland

1

Russia

1

Argentina

1

New Zealand

1

Peru

1

Israel

1

Taiwan

1

Mexico

1

South Africa

1

Lithuania

1

Saudi Arabia

1

Hungary

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic